AbscoTx
Year
2024
Area
Healthcare and Medical
Local delivery. Systemic response.
Absco Therapeutics, Inc. (AbscoTx) is an immune engineering company born out of collaborative work between clinicians at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH), engineers at MIT, and an experienced team of biotech entrepreneurs and translational medicine experts.
Stephen Linderman talks about effective drug delivery for immune system education at Ideastream 2025.
ImmunoGel to treat immunotherapy-resistant cancer
This company is a spinout from the 2021 project, ImmunoGel to treat immunotherapy-resistant cancer.